Densitometric analysis of G(αo) protein subunit levels from postmortem Alzheimer disease hippocampal and prefrontal cortical membranes

Alzheimer Disease and Associated Disorders

Volumn 14, Issue 1, 2000, Pages 53-57

  Kolasa, Krystyna ^a,b,d   Harrell, Lindy E ^a,b   Parsons, Dee S ^a,b   Powers, Richard ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b The University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Alzheimer disease; G( o) proteins; Western blot

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SUBUNIT;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DENSITOMETRY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; CASE CONTROL STUDY; CELL MEMBRANE; CHEMISTRY; MIDDLE AGED; PATHOPHYSIOLOGY; WESTERN BLOTTING;

AGED; ALZHEIMER DISEASE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL MEMBRANE; FEMALE; GTP-BINDING PROTEINS; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX;

EID: 0033621763     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200001000-00007     Document Type: Article

References (29)

1. Ayyagari PV, Gerber M, Joseph JA, Crews FT. Uncoupling of muscarinic cholinergic phosphoinositide signals in senescent cerebral cortical and hippocampal membranes. Neurochem Intern 1998;32: 107-15.
2. Birnbaumer L. G proteins in signal transduction. Annu Rev Pharmacol Toxicol 1990;30:675-705.
3. Birnbaumer L. Heterotrimetric G proteins molecular diversity and functional correlates. J Rec Res 1993;13:1-4.
4. Birnbaumer L, Perez-Reyes E, Bertrand P, et al. Molecular diversity and function of G proteins and calcium channels. Biol Reprod 1991; 44:207-24.
5. Brabet P, Pantaloni C, Rodriguez M, Martinez J, Bockaert J, Homburger V. Neuroblastoma differentiation involves the expression of two isoforms of the α-subunit of Go. J Neurochem 1990;54:1310-20.
6. Clapham DE. Direct G protein activation of ion channels? Annu Rev Neurosci 1994;17:441-64.
7. Coyle J, Price D, Delong M. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983;219:1184-90.
8. Hosey MM, Benovic JL, DebBurman SK, Richardson RM. Multiple mechanisms involving protein phosphorylation are linked to desensitization of muscarinic receptors. Life Sci 1995;56:951-5.
9. Jope RS, Song L, Li X, Powers R. Impaired phosphoinisitide hydrolysis in Alzheimer's disease brain. Neurobiol Aging 1994;15:221-6.
10. Jope RS, Song L, Powers RE. Cholinergic activation of phosphoinositide signalling is impaired in Alzheimer's disease brain. Neurobiol Aging 1997;18:111-20.
11. Joseph JA, Erat S, Denisova N, Villalobos-Molina R. Receptor- and age-selective effects of dopamine oxidation on receptor-G protein interactions in the striatum. Free Rad Biol Med 1998;24:827-34.
12. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985; 42:1097-1105.
13. Kolasa K, Harrell LE, Parsons DS. Effect of pertussis toxin and Gα protein specific antibodies on phosphoinositide hydrolysis in rat brain membranes after cholinergic denervation and hippocampal sympathetic ingrowth. Exp Neurol 1999 (in press).
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
15. Li X, Greenwood A, Powers R, Jope RS. Effects of postmortem interval, age, and Alzheimer's disease on G-proteins in human brain. Neurobiol Aging 1996;17:115-22.
16. Li X, Mumby SM, Greenwood A, Jope RS. Pertussis toxin-sensitive G protein a-subunit: production of monoclonal antibodies and detection of differential increases on differentiation of PC12 and LA-N-5 cells. J Neurochem 1995;64:1107-17.
17. Lowry OH, Rosenbrough NJ, Farr AL, Randall R. Protein measurement with the folin reagent. J Biol Chem 1951;193:265-75.
18. Malbon CC. Heterotrimetric G-proteins and development. Biochem Pharmacol 1997;53:1-4.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-44.
20. McLaughlin M, Ross BM, Milligan G, McCulloch J, Knowler JT. Robustness of G proteins in Alzheimer's disease: an immunoblot study. J Neurochem 1991;57:9-14.
21. McShea A, Zelasko DA, Gerst JL, Smith MA. Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. Brain Res 1999;815:237-42.
22. Mullaney I, Milligan G. Identification of two distinct isoforms of the quanine nucleotide binding protein Go in neuroblastoma X glioma hybrid cells: independent regulation during cyclic AMP-induced differentiation. J Neurochem 1990;55:1890-8.
23. o-subtype from mammalian brain. Biochem J 1994;300:387-94.
24. O'Neill C, Wiehager B, Fowler CJ, Ravid R, Winblad B, Cowburn RF. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain. Brain Res 1994;636:193-201.
25. Spicher K, Klinz FJ, Rudolph U, et al. Identification of the G-protein α-subunit encoded by α-o2 cDNA as a 39 kDa pertussis toxin substrate. Biochem Biophys Res Comm 1991;175:473-9.
26. Spicher K, Nurnberg B, Jager B, Rosenthal W, Schultz G. Heterogeneity of three electrophoretically distinct Go α-subunits in mammalian brain. Febs Lett 1992;307:215-8.
27. 2+ channels in mouse heart. Proc Natl Acad Sci U S A 1997;94:1727-32.
28. Wallace MA, Claro E. Transmembrane signaling through phospholipase C in human cortical membranes. Neurochem Res 1993;18:139-45.
29. Wang HY, Friedman E. Receptor-mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients. Neurosci Lett 1994;173:37-9.